Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures
- 1 January 1996
- Vol. 18 (1) , 9-14
- https://doi.org/10.1016/8756-3282(95)00426-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment of malignancy-associated hypercalcemia with YM175, a new bisphosphonate: elevated threshold for parathyroid hormone secretion in hypercalcemic patientsJournal of Clinical Endocrinology & Metabolism, 1994
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compoundJournal of Bone and Mineral Research, 1994
- Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancerBone, 1994
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Journal of Clinical Investigation, 1991
- BisphosphonatesDrugs, 1991
- BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionJournal of Bone and Mineral Research, 1991
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990
- Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.Journal of Clinical Investigation, 1989
- Diphosphonates inhibit bone resorption by macrophages in vitroThe Journal of Pathology, 1980